Shucheng Ye

Guhuai Road
Jining, 272000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Development and validation of a radiomics-dosiomics model for predicting radiotherapy response in locally advanced, unresectable non-small cell lung cancer: a multi-center study.

Development and validation of a radiomics-dosiomics model for predicting radiotherapy response in locally advanced, unresectable non-small cell lung cancer: a multi-center study.

Journal: Scientific reports

Published: December 02, 2025

The knowledge, attitude, and practice score on oral nutrition supplementation is inversely associated with malnutrition risk of tumor patients during the peri-radiotherapy period: a multicenter cross-sectional study.

The knowledge, attitude, and practice score on oral nutrition supplementation is inversely associated with malnutrition risk of tumor patients during the peri-radiotherapy period: a multicenter cross-sectional study.

Journal: Frontiers in nutrition

Published: November 25, 2025

Dynamic Granulocyte Turnover Inferred From cfDNA Methylation Predicts Immunotherapy Benefit in Liver-Metastatic Small Cell Lung Cancer: A Prospective Biomarker Study.

Dynamic Granulocyte Turnover Inferred From cfDNA Methylation Predicts Immunotherapy Benefit in Liver-Metastatic Small Cell Lung Cancer: A Prospective Biomarker Study.

Journal: MedComm

Published: September 17, 2025

Multicenter development of a deep learning radiomics and dosiomics nomogram to predict radiation pneumonia risk in non-small cell lung cancer.

Multicenter development of a deep learning radiomics and dosiomics nomogram to predict radiation pneumonia risk in non-small cell lung cancer.

Journal: Scientific reports

Published: December 25, 2024

Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial.

Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial.

Journal: Translational lung cancer research

Published: November 05, 2024

Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial.

Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 07, 2024

Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial.

Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial.

Journal: Cancer communications (London, England)

Published: November 11, 2023

A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinoma.

A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinoma.

Journal: Medicine

Published: March 17, 2023

HuR Stabilizes lnc-Sox5 mRNA to Promote Tongue Carcinogenesis.

HuR Stabilizes lnc-Sox5 mRNA to Promote Tongue Carcinogenesis.

Journal: Biochemistry. Biokhimiia

Published: April 04, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026